These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 15987980

  • 1. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
    Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA.
    Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
    [Abstract] [Full Text] [Related]

  • 2. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT.
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [Abstract] [Full Text] [Related]

  • 3. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
    Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK.
    Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
    [Abstract] [Full Text] [Related]

  • 4. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen-Auerbach M, Schiepers C, Herrmann K.
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [Abstract] [Full Text] [Related]

  • 5. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S, Li G, Bural G, Alavi A.
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [Abstract] [Full Text] [Related]

  • 6. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
    Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S.
    Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
    [Abstract] [Full Text] [Related]

  • 7. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
    Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, Boland GW.
    Radiology; 2006 Mar; 238(3):970-7. PubMed ID: 16505394
    [Abstract] [Full Text] [Related]

  • 8. Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images.
    Zhang C, Liao C, Penney BC, Appelbaum DE, Simon CA, Pu Y.
    Radiology; 2015 Jun; 275(3):862-9. PubMed ID: 25584710
    [Abstract] [Full Text] [Related]

  • 9. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
    Strobel K, Dummer R, Husarik DB, Pérez Lago M, Hany TF, Steinert HC.
    Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
    [Abstract] [Full Text] [Related]

  • 10. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A.
    Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
    [Abstract] [Full Text] [Related]

  • 11. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [Abstract] [Full Text] [Related]

  • 12. Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer.
    Collaud S, Lardinois D, Tischler V, Steinert HC, Stahel R, Weder W.
    Eur J Cardiothorac Surg; 2012 Mar; 41(3):612-6. PubMed ID: 22219415
    [Abstract] [Full Text] [Related]

  • 13. Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.
    Geiger GA, Kim MB, Xanthopoulos EP, Pryma DA, Grover S, Plastaras JP, Langer CJ, Simone CB, Rengan R.
    Clin Lung Cancer; 2014 Jan; 15(1):79-85. PubMed ID: 24238934
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
    Ho TY, Liou MJ, Lin KJ, Yen TC.
    Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
    [Abstract] [Full Text] [Related]

  • 15. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
    Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM.
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
    [Abstract] [Full Text] [Related]

  • 16. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M, Isidoro C, Aimaretti G.
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [Abstract] [Full Text] [Related]

  • 17. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.
    Takamochi K, Yoshida J, Murakami K, Niho S, Ishii G, Nishimura M, Nishiwaki Y, Suzuki K, Nagai K.
    Lung Cancer; 2005 Feb; 47(2):235-42. PubMed ID: 15639722
    [Abstract] [Full Text] [Related]

  • 18. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer.
    Lardinois D, Weder W, Roudas M, von Schulthess GK, Tutic M, Moch H, Stahel RA, Steinert HC.
    J Clin Oncol; 2005 Oct 01; 23(28):6846-53. PubMed ID: 16192576
    [Abstract] [Full Text] [Related]

  • 19. Oncocytic adenomas of thyroid-mimicking benign or metastatic disease on 18F-FDG-PET scan.
    Zandieh S, Pokieser W, Knoll P, Sonneck-Koenne C, Kudlacek M, Mirzaei S.
    Acta Radiol; 2015 Jun 01; 56(6):709-13. PubMed ID: 24948789
    [Abstract] [Full Text] [Related]

  • 20. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.
    Radiology; 2007 Jul 01; 244(1):257-62. PubMed ID: 17581905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.